Compounding may be permitted under specific federal and state rules when applicable requirements are met, but that framework differs meaningfully from the FDA approval process for the branded drugs themselves
This dual mechanism can sometimes lead to greater improvements in blood sugar control and more significant weight loss for some patients compared to GLP-1 agonists alone
Due to tirzepatide's long half-life (approximately five days) and delayed peak concentration (8-72 hours after injection), symptoms typically reflect steady-state effects rather than immediate post-injection peaks
Lee says, citing medspas, local clinics, and telehealth providers as potential sources
While initially introduced as a treatment for type-2 diabetes, patients taking glucagon-like peptide 1 (GLP-1) receptor agonists (see Text Box 1) found a discrete change in the amount and types of food they desire, including the curbing of cravings for certain less nutritious categories of foods (e.g., sweets, fried foods), which helped patients who were overweight or obese lose clinically significant amounts of weight and, with continued use, to maintain weights 15%20% lower than premedication levels (Rubino et al., 2021, Aronne et al., 2024)
On that site, Wegovy injectables range in price from $199 for a lower dosage for the first two months to $399 for a higher dosage
